Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
5.35
-0.03 (-0.56%)
At close: Dec 5, 2025
HKG:9989 Market Cap
HKG:9989 has a market cap or net worth of 17.74 billion as of December 5, 2025. Its market cap has increased by 8.69% in one year.
Market Cap
17.74B
Enterprise Value
17.80B
Revenue
5.88B
Ranking
n/a
PE Ratio
38.63
Stock Price
5.35
Market Cap Chart
Since May 6, 2010, HKG:9989's market cap has decreased from 79.74B to 17.74B, a decrease of -77.75%. That is a compound annual growth rate of -9.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 17.74B | 17.79% |
| Dec 31, 2024 | 15.06B | -10.92% |
| Dec 29, 2023 | 16.91B | -12.50% |
| Dec 30, 2022 | 19.32B | -30.93% |
| Dec 31, 2021 | 27.97B | -0.50% |
| Dec 31, 2020 | 28.11B | 3.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 284.43B |
| Hansoh Pharmaceutical Group Company | 243.25B |
| JD Health International | 192.25B |
| Innovent Biologics | 157.33B |
| WuXi Biologics | 126.66B |
| Sino Biopharmaceutical | 120.67B |
| Akeso | 108.88B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.18B |